Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455123001229 |
_version_ | 1827355966362877952 |
---|---|
author | Fatma Merve Tepetam, MD Şeyma Özden, MD Fatma Kübra Kılıç, MD Cihan Örçen, MD Tuğçe Yakut, MD |
author_facet | Fatma Merve Tepetam, MD Şeyma Özden, MD Fatma Kübra Kılıç, MD Cihan Örçen, MD Tuğçe Yakut, MD |
author_sort | Fatma Merve Tepetam, MD |
collection | DOAJ |
first_indexed | 2024-03-08T04:51:00Z |
format | Article |
id | doaj.art-cfe8e5013c1945fe82bd2c350781974d |
institution | Directory Open Access Journal |
issn | 1939-4551 |
language | English |
last_indexed | 2024-03-08T04:51:00Z |
publishDate | 2024-02-01 |
publisher | Elsevier |
record_format | Article |
series | World Allergy Organization Journal |
spelling | doaj.art-cfe8e5013c1945fe82bd2c350781974d2024-02-08T05:07:33ZengElsevierWorld Allergy Organization Journal1939-45512024-02-01172100861Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]Fatma Merve Tepetam, MD0Şeyma Özden, MD1Fatma Kübra Kılıç, MD2Cihan Örçen, MD3Tuğçe Yakut, MD4University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, Turkey; Corresponding author. University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Basibuyuk Mahallesi, Maltepe, 34854, Istanbul, Turkey.University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, TurkeyUniversity of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, TurkeyUniversity of Health Sciences, Derince Training and Research Hospital, Kocaeli, TurkeyUniversity of Health Sciences, Diyarbakır Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkeyhttp://www.sciencedirect.com/science/article/pii/S1939455123001229 |
spellingShingle | Fatma Merve Tepetam, MD Şeyma Özden, MD Fatma Kübra Kılıç, MD Cihan Örçen, MD Tuğçe Yakut, MD Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817] World Allergy Organization Journal |
title | Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817] |
title_full | Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817] |
title_fullStr | Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817] |
title_full_unstemmed | Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817] |
title_short | Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817] |
title_sort | erratum to does nsaid exacerbated respiratory disease n erd accompanying severe asthma affect biological treatment response efficacy of omalizumab and mepolizumab in n erd world allergy organ 2023 100817 |
url | http://www.sciencedirect.com/science/article/pii/S1939455123001229 |
work_keys_str_mv | AT fatmamervetepetammd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817 AT seymaozdenmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817 AT fatmakubrakılıcmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817 AT cihanorcenmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817 AT tugceyakutmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817 |